Lista de obras -

A New Multi-clade DNA Prime/Recombinant MVA Boost Vaccine Induces Broad and High Levels of HIV-1-specific CD8+ T-cell and Humoral Responses in Mice

article

An affibody-adalimumab hybrid blocks combined IL-6 and TNF-triggered serum amyloid A secretion in vivo

artículo científico publicado en 2014

Autoimmunogenicity of the helix-loop-helix DNA-binding domain

artículo científico publicado en 2009

Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation

article

Broad and potent cellular and humoral immune responses after a second late HIV-modified vaccinia virus ankara vaccination in HIV-DNA-primed and HIV-modified vaccinia virus Ankara-boosted Swedish vaccinees

artículo científico publicado en 2013

Challenges of Global Vaccine Development.

artículo científico publicado en 2008

Circulating monocytes are not the major source of plasma cytokines in patients with sepsis

artículo científico publicado en 2012

Correction: Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification.

artículo científico publicado en 2013

Elevated levels of serum perforin in chronic HIV-1 and acute SIV/SHIV infection

article

Engineering of a bispecific affibody molecule towards HER2 and HER3 by addition of an albumin-binding domain allows for affinity purification and in vivo half-life extension.

artículo científico publicado en 2014

Evaluation of the Therapeutic Potential of a HER3-Binding Affibody Construct TAM-HER3 in Comparison with a Monoclonal Antibody, Seribantumab

artículo científico publicado en 2018

Immunization of mice with the nef gene from Human Immunodeficiency Virus type 1: study of immunological memory and long-term toxicology.

artículo científico publicado en 2007

Immunotherapy with an HIV-DNA Vaccine in Children and Adults.

artículo científico publicado en 2014

Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification

artículo científico publicado en 2013

Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen

artículo científico publicado en 2009

Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunization

artículo científico publicado en 2008

Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity

artículo científico publicado en 2009

Short-term HIV-1 treatment interruption is associated with dysregulated TLR-stimuli responsiveness

artículo científico publicado en 2013

Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment

artículo científico publicado en 2009

The PEDVAC trial: preliminary data from the first therapeutic DNA vaccination in HIV-infected children

artículo científico publicado en 2011

Therapeutic immunization for HIV.

artículo científico publicado en 2006

Lista de obras de

A New Multi-clade DNA Prime/Recombinant MVA Boost Vaccine Induces Broad and High Levels of HIV-1-specific CD8+ T-cell and Humoral Responses in Mice

An affibody-adalimumab hybrid blocks combined IL-6 and TNF-triggered serum amyloid A secretion in vivo

Autoimmunogenicity of the helix-loop-helix DNA-binding domain

Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation

Broad and potent cellular and humoral immune responses after a second late HIV-modified vaccinia virus ankara vaccination in HIV-DNA-primed and HIV-modified vaccinia virus Ankara-boosted Swedish vaccinees

Challenges of Global Vaccine Development.

Circulating monocytes are not the major source of plasma cytokines in patients with sepsis

Correction: Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification.

Elevated levels of serum perforin in chronic HIV-1 and acute SIV/SHIV infection

Engineering of a bispecific affibody molecule towards HER2 and HER3 by addition of an albumin-binding domain allows for affinity purification and in vivo half-life extension.

Evaluation of the Therapeutic Potential of a HER3-Binding Affibody Construct TAM-HER3 in Comparison with a Monoclonal Antibody, Seribantumab

Immunization of mice with the nef gene from Human Immunodeficiency Virus type 1: study of immunological memory and long-term toxicology.

Immunotherapy with an HIV-DNA Vaccine in Children and Adults.

Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification

Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen

Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunization

Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity

Short-term HIV-1 treatment interruption is associated with dysregulated TLR-stimuli responsiveness

Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment

The PEDVAC trial: preliminary data from the first therapeutic DNA vaccination in HIV-infected children

Therapeutic immunization for HIV.